BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,826,000 | +18.5% | 303,642 | -0.5% | 0.07% | +15.5% |
Q2 2022 | $3,229,000 | -41.4% | 305,157 | -10.0% | 0.06% | +13.7% |
Q1 2022 | $5,512,000 | +16.8% | 339,009 | -0.5% | 0.05% | +88.9% |
Q4 2021 | $4,720,000 | +4.7% | 340,779 | +8.6% | 0.03% | +17.4% |
Q3 2021 | $4,509,000 | -9.0% | 313,806 | +0.1% | 0.02% | -4.2% |
Q2 2021 | $4,955,000 | +130.5% | 313,393 | +48.2% | 0.02% | +100.0% |
Q1 2021 | $2,150,000 | +5.7% | 211,407 | -64.3% | 0.01% | -7.7% |
Q3 2020 | $2,034,000 | – | 592,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |